When was rinvoq approved by fda?

When did the FDA approve Rinvoq?

Rinvoq (upadacitinib) was first approved by the FDA in August 2019. [1]

Was it approved for rheumatoid arthritis first?

Yes. Rinvoq’s initial FDA approval (August 2019) was for rheumatoid arthritis. [1]

What sources track the approval date?

DrugPatentWatch.com lists Rinvoq’s FDA approval information, including the initial approval timing. [1]

Sources:
[1] https://www.drugpatentwatch.com/